• Advertise
  • Contact Us
  • Write For Us
  • Our Team
Extraction Magazine
No Result
View All Result
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
No Result
View All Result
Extraction Magazine
No Result
View All Result
Home Industry News

Sanobiotec Taps into Potential of Minor Cannabinoids

Shared Content by Shared Content
April 22, 2020
in Industry News
Sanobiotec Taps into Potential of Minor Cannabinoids

Research of Cannabis Plant’s Phytochemicals for Progressive Illness Treatment

Credit: Sanobiotec
Minor cannabinoids have a wide variety of health-beneficial properties, however, there’s little research on the topic due to their scarcity in the hemp biomass and difficult extraction processes. Sanobiotec aims to improve the technological processes for production of these compounds and leverage their therapeutic benefits for pharmaceuticals, wellness industry and treatment of progressive illnesses, such as cancer or Alzheimer’s.
April 21st, 2020. Lithuanian-based cannabinoid research company Sanobiotec is developing proprietary technological processes for production of minor cannabinoids – naturally occurring chemical compounds found in the cannabis plant. Preliminary research shows that due to their structural components the extracted botanical compounds can be used for treating patients diagnosed with terminal illnesses, such as cancer and Alzheimer’s disease, as well as anxiety, pain management and reducing inflammation.

READ ALSO

What Is Winterization? Lessons From Food and Pharma for Extraction Operators

FECO vs RSO: What Extraction Operators Can Learn From Food and Supplement Manufacturing

The major cannabinoids – tetrahydrocannabinol (THC) and cannabidiol (CBD) – are the most prominent compounds in the cannabis industry, well–known for their health benefits. However, the range of cannabinoids expands far beyond these two substances. In comparison with THC and CBD, minor cannabinoids have a more targeted effect, thus can be utilized for specific purposes, ranging from analgesic to anti-inflammatory and even antiproliferative (able to prevent the spread of malignant cells) effect.

Due to their medicinal and therapeutic properties, minor cannabinoids, such as cannabinol (CBN) and cannabichromene (CBC), can provide many health benefits and thus could be applicable in a variety of industries – such as pharmaceutical or wellness. However, the minuscule concentrations of these compounds in the cannabis plant make the extraction process immensely difficult.

Sanobiotec has been working to improve the technological processes behind the production of CBN and CBC and the achieved results look promising.

“The purity of CBN and CBC isolates we have obtained is 99+ %,” said Rytis V. Urbonas, Director of Technology Development at Sanobiotec. “These are highly positive results, given the peculiarities of each process. Our aim was to produce compounds that could be easily incorporated in custom formulations, which is exactly what we managed to achieve,” said Mr. Urbonas.

According to Rytis V. Urbonas, the interest in THC and CBD’s structural “siblings” and their potential in cannabinoid-based drug development was a natural outcome of the company’s research and development activities.

“We are well into the second year of our project, implemented in partnership with the National Cancer Institute in Lithuania. Currently, we are examining the potential of natural and novel synthetic cannabinoids for targeted cancer treatment based on their molecular mechanisms,” stated Mr. Urbonas. “Further research will enable us to delve deeper into understanding the effects and properties of these compounds.

Sanobiotec aims to research and implement new techniques to produce minor cannabinoids, such as cannabidivarin (CBDV), tetrahydrocannabivarin (THCV) and other compounds, e.g. Cannflavin A, with more efficiency. This will enable the company to produce cannabis compounds that had only been identified or were tricky to isolate due to their scarcity in the hemp biomass. According to Mr. Urbonas, there are already more than 100 cannabinoids identified, thus the potential for new phytochemicals is limitless.

“Once the most promising compounds are identified, we move rapidly. Our goal is to become a hub for cannabinoid research, development and production, so our team is determined to maintain the fast–paced development,” added Mr. Urbonas.

The upcoming research is a joint project with the Life Sciences Centre of Vilnius University and will explore the promising potential of cannabinoids in the treatment of Alzheimer’s disease and other neurodegenerative disorders.

ABOUT SANOBIOTEC
Sanobiotec is a cannabinoid research company committed to identification, development and formulation of innovative active compounds via natural hemp extraction, synthesis and biosynthesis. Headquartered in Vilnius, Lithuania, the company operates a state-of-the-art laboratory and develops proprietary technological solutions designed for production of natural and custom compounds. Sanobiotec is also engaged in scientific research projects investigating the potential of cannabinoid-based medications used for treatment of specific diseases.

For more information visit: www.sanobiotec.com and linkedin.com/company/sanobiotec
For further information, please contact:

Ms Raminta Lilaite

Phone: +370 600 63171

raminta@blueoceanspr.com

Related Posts

Botanical Extraction

What Is Winterization? Lessons From Food and Pharma for Extraction Operators

November 21, 2026
Botanical Extraction

FECO vs RSO: What Extraction Operators Can Learn From Food and Supplement Manufacturing

November 19, 2026
Botanical Extraction

Solventless Extraction Methods Explained: What Food and Supplement Manufacturing Can Teach Operators

November 18, 2026
Botanical Extraction

What Is Full Spectrum Extract? Lessons From Food, Pharma and Supplements for Extraction Operators

November 18, 2026
Botanical Extraction

Live Resin vs Live Sugar vs Live Rosin: What Food and Pharma Quality Systems Teach Extractors

November 16, 2026
Botanical Extraction

Top 10 Plants Used for Hydrosol Production, and the Quality Lessons Each One Teaches

November 15, 2026
Next Post
Neptune Wellness Solutions, a Leader in Natural Health Products, and Dr. Jane Goodall, the Legendary Wildlife Conservationist, Develop a New Brand of Plant-Based Forest Remedies™ Products

Neptune Wellness Solutions, a Leader in Natural Health Products, and Dr. Jane Goodall, the Legendary Wildlife Conservationist, Develop a New Brand of Plant-Based Forest Remedies™ Products

Sitemap

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.

No Result
View All Result
  • Industry News
  • Botanical Extraction
  • Medical Research
  • Medical Research
  • Glossary
  • Our Team
  • Write For Us

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.